MedTech Dive March 5, 2024
Attune’s device to help cool the esophagus during radiofrequency ablation procedures is a key piece of the acquisition.
Dive Brief:
- Haemonetics said Tuesday it has agreed to pay $160 million upfront to acquire Attune Medical, maker of a device to protect the esophagus from injury during radiofrequency cardiac ablation procedures. The agreement includes undisclosed additional payments based on reaching sales growth and other milestones.
- Radiofrequency ablation is used to treat atrial fibrillation, a form of irregular heartbeat. In the procedure, heat energy creates small scars in the heart to block the faulty electrical signals.
- Attune’s device is placed in the esophagus and connected to an external heat exchange unit to create a temperature management system to cool the esophagus...
Today's Sponsors
Today's Sponsor